Circulation

publication venue for

2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. 2022
Neonatal Life Support: 2020 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2020
The Variety of Cardiovascular Presentations of COVID-19. 2020
Interventional Therapies for Acute Pulmonary Embolism: Current Status and Principles for the Development of Novel Evidence: A Scientific Statement From the American Heart Association. 2019
Cardio-Oncology Rehabilitation to Manage Cardiovascular Outcomes in Cancer Patients and Survivors: A Scientific Statement From the American Heart Association. 2019
The 2013 American Heart Association/American College of Cardiology/The Obesity Society Guideline for the Management of Overweight and Obesity in Adults: What Is New About Diet, Drugs, and Surgery for Obesity? 2015
Task Force 3: Pediatric Cardiology Fellowship Training in Cardiac Catheterization. SPCTPD/ACC/AAP/AHA. 2015
Deceptive nature of atrial premature contractions: ablating 2 arrhythmias with 1 burn. 2014
Assessment of the 12-lead ECG as a screening test for detection of cardiovascular disease in healthy general populations of young people (12-25 Years of Age): a scientific statement from the American Heart Association and the American College of Cardiology. 2014
Exercise standards for testing and training: a scientific statement from the American Heart Association. 2013
Phase II clinical research design in cardiology: learning the right lessons too well: observations and recommendations from the Cardiovascular Cell Therapy Research Network (CCTRN). 2013
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 2012
2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS guideline for the diagnosis and management of patients with stable ischemic heart disease: executive summary: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines, and the American College of Physicians, American Association for Thoracic Surgery, Preventive Cardiovascular Nurses Association, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. 2012
Serial cardiac magnetic resonance imaging of a rapidly progressing liquefaction necrosis of mitral annulus calcification associated with embolic stroke. 2012
Peripheral phenomena in a woman with calcinosis, raynaud phenomenon, esophageal dysmotility, sclerodactyly, and telangiectasia (CREST) syndrome-associated pulmonary hypertension. 2012
Ventricular assist device-associated thrombus. 2011
2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. 2011
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (update on Dabigatran): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. 2011
ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents. 2010
ACCF/SCCT/ACR/AHA/ASE/ASNC/NASCI/SCAI/SCMR 2010 Appropriate Use Criteria for Cardiac Computed Tomography. A Report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, the Society of Cardiovascular Computed Tomography, the American College of Radiology, the American Heart Association, the American Society of Echocardiography, the American Society of Nuclear Cardiology, the North American Society for Cardiovascular Imaging, the Society for Cardiovascular Angiography and Interventions, and the Society for Cardiovascular Magnetic Resonance. 2010
Images in cardiovascular medicine. Double-chambered right ventricle and situs inversus with dextrocardia. 2010
Prevention of torsade de pointes in hospital settings: a scientific statement from the American Heart Association and the American College of Cardiology Foundation. 2010
Images in cardiovascular medicine. Rare case of an unroofed coronary sinus: diagnosis by multidetector computed tomography. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part III: intraventricular conduction disturbances: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part IV: the ST segment, T and U waves, and the QT interval: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part V: electrocardiogram changes associated with cardiac chamber hypertrophy: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. 2009
AHA/ACCF/HRS recommendations for the standardization and interpretation of the electrocardiogram: part VI: acute ischemia/infarction: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. 2009
Images in cardiovascular medicine. Giant left circumflex coronary artery aneurysm with arteriovenous fistula to the coronary sinus. 2008
Images in cardiovascular medicine. The traveling amplatzer: rare complication of percutaneous atrial septal occluder device embolism. 2008
Images in cardiovascular medicine. Calcified amorphous tumor of the heart. 2008
Assessment of functional capacity in clinical and research settings: a scientific statement from the American Heart Association Committee on Exercise, Rehabilitation, and Prevention of the Council on Clinical Cardiology and the Council on Cardiovascular Nursing. 2007
Recommendations for the standardization and interpretation of the electrocardiogram: part I: The electrocardiogram and its technology: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. 2007
Recommendations for the standardization and interpretation of the electrocardiogram: part II: Electrocardiography diagnostic statement list: a scientific statement from the American Heart Association Electrocardiography and Arrhythmias Committee, Council on Clinical Cardiology; the American College of Cardiology Foundation; and the Heart Rhythm Society: endorsed by the International Society for Computerized Electrocardiology. 2007
Images in cardiovascular medicine. Cardiac leiomyosarcoma. 2007
Images in cardiovascular medicine. Myocardial fibroma in gorlin syndrome by cardiac magnetic resonance imaging. 2006
ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. 2006
Relationship between procedure indications and outcomes of percutaneous coronary interventions by American College of Cardiology/American Heart Association Task Force Guidelines. 2005
Role of noninvasive testing in the clinical evaluation of women with suspected coronary artery disease: Consensus statement from the Cardiac Imaging Committee, Council on Clinical Cardiology, and the Cardiovascular Imaging and Intervention Committee, Council on Cardiovascular Radiology and Intervention, American Heart Association. 2005
Cardiac arrest and cardiopulmonary resuscitation outcome reports: update and simplification of the Utstein templates for resuscitation registries: a statement for healthcare professionals from a task force of the International Liaison Committee on Resuscitation (American Heart Association, European Resuscitation Council, Australian Resuscitation Council, New Zealand Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Councils of Southern Africa). 2004
Principles for national and regional guidelines on cardiovascular disease prevention: a scientific statement from the World Heart and Stroke Forum. 2004
ACC/AHA/ESC guidelines for the management of patients with supraventricular arrhythmias--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Supraventricular Arrhythmias). 2003
Images in cardiovascular medicine. Tako-tsubo--like transient left ventricular dysfunction. 2003
American College of Cardiology/American Heart Association clinical competence statement on echocardiography: a report of the American College of Cardiology/American Heart Association/American College of Physicians--American Society of Internal Medicine Task Force on Clinical Competence. 2003
ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conferences (Committee to Develop Guidelines for the Management of Patients With Atrial Fibrillation) Developed in Collaboration With the North American Society of Pacing and Electrophysiology. 2001
Recommendations for the management of intracranial arteriovenous malformations: a statement for healthcare professionals from a special writing group of the Stroke Council, American Stroke Association. 2001
Images in cardiovascular medicine. Fistula between left main, left anterior descending, and pulmonary arteries. 1998
Images in cardiovascular medicine. Calcific aortic stenosis and associated Lev's disease. 1995
Images in Cardiovascular medicine. Noninvasive diagnosis of cor triatriatum. 1995
Preventing heart attack and death in patients with coronary disease. 1995
Diagnosing and managing unstable angina. Agency for Health Care Policy and Research. 1994
Myocardial free-wall rupture after acute infarction: survival aided by percutaneous intraaortic balloon counterpulsation. 1982
Graft Failure After Coronary Artery Bypass Grafting and Its Association With Patient Characteristics and Clinical Events: A Pooled Individual Patient Data Analysis of Clinical Trials With Imaging Follow-Up. 2023
ROMA-Women: Innovative Approaches for the First Cardiac Surgery Trial in Women. 2023
Right Internal Thoracic Artery for Coronary Bypass Surgery: Did We Get It Wrong?. 146. 2022
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.. 145. 2021
The Use of Intraoperative Transit Time Flow Measurement for Coronary Artery Bypass Surgery: Systematic Review of the Evidence and Expert Opinion Statements.. 144. 2021
Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation.. 143. 2021
Number of Social Determinants of Health and Fatal and Nonfatal Incident Coronary Heart Disease in the REGARDS Study.. 143. 2020
Myocardial Injury in Adults Hospitalized With COVID-19.. 142. 2020
Epigenetic Reader BRD4 (Bromodomain-Containing Protein 4) Governs Nucleus-Encoded Mitochondrial Transcriptome to Regulate Cardiac Function.. 142. 2020
Forty-Year Shifting Distribution of Systolic Blood Pressure With Population Hypertension Treatment and Control.. 142. 2020
Long-Term Results of the RAPCO Trials.. 142. 2020
Postoperative Atrial Fibrillation and Long-Term Risk of Stroke After Isolated Coronary Artery Bypass Graft Surgery.. 142. 2020
Impact of Transcatheter Aortic Valve Durability on Life Expectancy in Low-Risk Patients With Severe Aortic Stenosis.. 142. 2020
New York City Innocence Lost: Cardiology in the COVID-19 Pandemic.. 141. 2020
Guidance for Cardiac Electrophysiology During the COVID-19 Pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association.. 141. 2020
Effects of Exercise Therapy Dosing Schedule on Impaired Cardiorespiratory Fitness in Patients With Primary Breast Cancer: A Randomized Controlled Trial.. 141. 2020
Microvascular Disease, Peripheral Artery Disease, and Amputation.. 140. 2019
Polycystin-1 Assembles With Kv Channels to Govern Cardiomyocyte Repolarization and Contractility.. 140. 2019
Impact of Bridge to Transplantation With Continuous-Flow Left Ventricular Assist Devices on Posttransplantation Mortality.. 140. 2019
Inducible Pluripotent Stem Cell-Derived Cardiomyocytes Reveal Aberrant Extracellular Regulated Kinase 5 and Mitogen-Activated Protein Kinase Kinase 1/2 Signaling Concomitantly Promote Hypertrophic Cardiomyopathy in RAF1-Associated Noonan Syndrome.. 140. 2019
Fibroblast Primary Cilia Are Required for Cardiac Fibrosis.. 139. 2019
Thyroid and Cardiovascular Disease Research Agenda for Enhancing Knowledge, Prevention, and Treatment. 2019
Potential Cardiovascular Disease Events Prevented with Adoption of the 2017 American College of Cardiology/American Heart Association Blood Pressure Guideline.. 139. 2019
Multiple Arterial Grafting Is Associated With Better Outcomes for Coronary Artery Bypass Grafting Patients.. 138. 2018
Fractional Flow Reserve and Quality-of-Life Improvement After Percutaneous Coronary Intervention in Patients With Stable Coronary Artery Disease.. 138. 2018
B-Type Natriuretic Peptide Assessment in Patients Undergoing Revascularization for Left Main Coronary Artery Disease: Analysis From the EXCEL Trial.. 138. 2018
Association of Human Immunodeficiency Virus Infection and Risk of Peripheral Artery Disease.. 138. 2018
PCSK9 Variants, Low-Density Lipoprotein Cholesterol, and Neurocognitive Impairment: Reasons for Geographic and Racial Differences in Stroke Study (REGARDS).. 137. 2017
Pioglitazone Prevents Stroke in Patients With a Recent Transient Ischemic Attack or Ischemic Stroke: A Planned Secondary Analysis of the IRIS Trial (Insulin Resistance Intervention After Stroke).. 137. 2017
Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: Primary Results From the BIONICS Trial (BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis).. 136. 2017
Black-White Differences in Incident Fatal, Nonfatal, and Total Coronary Heart Disease.. 136. 2017
Incident Cardiovascular Disease Among Adults With Blood Pressure <140/90 mm Hg.. 136. 2017
Associations Between Adding a Radial Artery Graft to Single and Bilateral Internal Thoracic Artery Grafts and Outcomes: Insights From the Arterial Revascularization Trial.. 136. 2017
Prospective Study of Adenosine on Atrioventricular Nodal Conduction in Pediatric and Young Adult Patients After Heart Transplantation.. 135. 2017
Prognostic Value of Noninvasive Cardiovascular Testing in Patients With Stable Chest Pain: Insights From the PROMISE Trial (Prospective Multicenter Imaging Study for Evaluation of Chest Pain).. 135. 2017
Impact of Practice-Based Management of Pulmonary Artery Pressures in 2000 Patients Implanted With the CardioMEMS Sensor.. 135. 2017
Citizen Petition to the US Food and Drug Administration to Change Prescribing Guidelines: The Metformin Experience.. 134. 2016
Variations in Abdominal Aortic Aneurysm Care: A Report From the International Consortium of Vascular Registries.. 134. 2016
Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis.. 134. 2016
Treatment of Higher-Risk Patients With an Indication for Revascularization: Evolution Within the Field of Contemporary Percutaneous Coronary Intervention.. 134. 2016
The Heart of 25 by 25: Achieving the Goal of Reducing Global and Regional Premature Deaths From Cardiovascular Diseases and Stroke: A Modeling Study From the American Heart Association and World Heart Federation.. 133. 2016
Invasive Assessment of Coronary Physiology Predicts Late Mortality After Heart Transplantation.. 133. 2016
Association of Serum Lipids and Coronary Heart Disease in Contemporary Observational Studies.. 133. 2015
Critical Roles of STAT3 in β-Adrenergic Functions in the Heart.. 133. 2015
Cardiology Patient Page. ABCDE Steps for Heart and Vascular Wellness Following a Prostate Cancer Diagnosis.. 132. 2015
Depression and human immunodeficiency virus infection are risk factors for incident heart failure among veterans: Veterans Aging Cohort Study.. 132. 2015
Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study.. 132. 2015
Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study.. 131. 2015
Fibroblast growth factor 21 prevents atherosclerosis by suppression of hepatic sterol regulatory element-binding protein-2 and induction of adiponectin in mice.. 131. 2015
Oxidative stress activates endothelial innate immunity via sterol regulatory element binding protein 2 (SREBP2) transactivation of microRNA-92a.. 131. 2014
Transdifferentiation of human fibroblasts to endothelial cells: role of innate immunity.. 131. 2014
Relation of antiphospholipid antibodies to postmortem brain infarcts in older people.. 131. 2014
CD82 restrains pathological angiogenesis by altering lipid raft clustering and CD44 trafficking in endothelial cells.. 130. 2014
Cost-effectiveness of follow-up of pulmonary nodules incidentally detected on cardiac computed tomographic angiography in patients with suspected coronary artery disease.. 130. 2014
Mesenchymal precursor cells as adjunctive therapy in recipients of contemporary left ventricular assist devices.. 129. 2014
Fibromuscular dysplasia: state of the science and critical unanswered questions: a scientific statement from the American Heart Association.. 129. 2014
Racial and regional differences in venous thromboembolism in the United States in 3 cohorts.. 129. 2014
Ryanodine receptor-mediated calcium leak drives progressive development of an atrial fibrillation substrate in a transgenic mouse model.. 129. 2014
Growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery.. 129. 2013
Vascular progenitors from cord blood-derived induced pluripotent stem cells possess augmented capacity for regenerating ischemic retinal vasculature.. 129. 2013
Alloantibody and complement promote T cell-mediated cardiac allograft vasculopathy through noncanonical nuclear factor-κB signaling in endothelial cells.. 128. 2013
Comparison of transendocardial and intracoronary CD34+ cell transplantation in patients with nonischemic dilated cardiomyopathy.. 128. 2013
Primary arterial switch operation as a strategy for total correction of Taussig-Bing anomaly: a 21-year experience.. 128. 2013
Unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine.. 128. 2013
Adoption of radial access and comparison of outcomes to femoral access in percutaneous coronary intervention: an updated report from the national cardiovascular data registry (2007-2012).. 127. 2013
Sex differences in the effectiveness of early coronary computed tomographic angiography compared with standard emergency department evaluation for acute chest pain: the rule-out myocardial infarction with Computer-Assisted Tomography (ROMICAT)-II Trial.. 127. 2013
Management of patients with atrial fibrillation (compilation of 2006 ACCF/AHA/ESC and 2011 ACCF/AHA/HRS recommendations): a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines.. 127. 2013
Pulmonary hyperinflation and left ventricular mass: the Multi-Ethnic Study of Atherosclerosis COPD Study.. 127. 2013
Genome- and phenome-wide analyses of cardiac conduction identifies markers of arrhythmia risk.. 127. 2013
Prospective, multicenter study of ventricular assist device infections.. 127. 2013
Short- and long-term outcomes of coronary stenting in women versus men: results from the National Cardiovascular Data Registry Centers for Medicare & Medicaid services cohort.. 126. 2012
Coronary artery bypass grafting using the radial artery: clinical outcomes, patency, and need for reintervention.. 126. 2012
A prospective, randomized clinical trial of hemodynamic support with Impella 2.5 versus intra-aortic balloon pump in patients undergoing high-risk percutaneous coronary intervention: the PROTECT II study.. 126. 2012
Cyclooxygenase-2-derived prostacyclin regulates arterial thrombus formation by suppressing tissue factor in a sirtuin-1-dependent-manner.. 126. 2012
Association between major perioperative hemorrhage and stroke or Q-wave myocardial infarction.. 126. 2012
β-adrenergic receptor stimulation transactivates protease-activated receptor 1 via matrix metalloproteinase 13 in cardiac cells.. 125. 2012
Ventricular assist device implantation corrects myocardial lipotoxicity, reverses insulin resistance, and normalizes cardiac metabolism in patients with advanced heart failure.. 125. 2012
In Memoriam of John T. Shepherd, MD, DSc.. 125. 2012
An unsuspected property of natriuretic peptides: promotion of calcium-dependent catecholamine release via protein kinase G-mediated phosphodiesterase type 3 inhibition.. 125. 2011
Clinical implications of electrocardiographic left ventricular strain and hypertrophy in asymptomatic patients with aortic stenosis: the Simvastatin and Ezetimibe in Aortic Stenosis study.. 125. 2011
Randomized trial of cutting balloon compared with high-pressure angioplasty for the treatment of resistant pulmonary artery stenosis.. 124. 2011
Anticoagulation with the oral direct thrombin inhibitor dabigatran does not enlarge hematoma volume in experimental intracerebral hemorrhage.. 124. 2011
Clinical and economic outcomes of liberal versus selective drug-eluting stent use: insights from temporal analysis of the multicenter Evaluation of Drug Eluting Stents and Ischemic Events (EVENT) registry.. 124. 2011
Randomized clinical trial of aspirin and simvastatin for pulmonary arterial hypertension: ASA-STAT.. 123. 2011
Identification and classification of acute cardiac rejection by intragraft transcriptional profiling.. 123. 2011
Reversal of hyperlipidemia with a genetic switch favorably affects the content and inflammatory state of macrophages in atherosclerotic plaques.. 123. 2011
Humanized mouse model of thrombosis is predictive of the clinical efficacy of antiplatelet agents.. 123. 2011
2011 ACCF/AHA/HRS focused update on the management of patients with atrial fibrillation (updating the 2006 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.. 123. 2010
Heart disease and stroke statistics--2011 update: a report from the American Heart Association.. 123. 2010
Magnetic resonance imaging of carotid atherosclerotic plaque in clinically suspected acute transient ischemic attack and acute ischemic stroke.. 122. 2010
Post-heart transplant survival is inferior at low-volume centers across all risk strata.. 122. 2010
Aldehyde dehydrogenase activation prevents reperfusion arrhythmias by inhibiting local renin release from cardiac mast cells.. 122. 2010
Evaluation of a new heparin agent in percutaneous coronary intervention: results of the phase 2 evaluation of M118 IN pErcutaNeous Coronary intErvention (EMINENCE) Trial.. 121. 2010
High-sensitivity troponin T concentrations in acute chest pain patients evaluated with cardiac computed tomography.. 121. 2010
Executive summary: heart disease and stroke statistics--2010 update: a report from the American Heart Association.. 121. 2010
Nitrite potently inhibits hypoxic and inflammatory pulmonary arterial hypertension and smooth muscle proliferation via xanthine oxidoreductase-dependent nitric oxide generation.. 121. 2009
Heart disease and stroke statistics--2010 update: a report from the American Heart Association.. 121. 2009
Hyperhomocysteinemia promotes inflammatory monocyte generation and accelerates atherosclerosis in transgenic cystathionine beta-synthase-deficient mice.. 120. 2009
Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).. 119. 2009
Local inflammation and hypoxia abolish the protective anticontractile properties of perivascular fat in obese patients.. 119. 2009
Reciprocal regulation of myocardial microRNAs and messenger RNA in human cardiomyopathy and reversal of the microRNA signature by biomechanical support.. 119. 2009
Weekend versus weekday admission and mortality after acute pulmonary embolism.. 119. 2009
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.. 119. 2009
Heart disease and stroke statistics--2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee.. 119. 2008
Prevalence, prognosis, and implications of isolated minor nonspecific ST-segment and T-wave abnormalities in older adults: Cardiovascular Health Study.. 118. 2008
Predictive value of myocardial perfusion single-photon emission computed tomography and the impact of renal function on cardiac death.. 118. 2008
Electrophysiological consequences of acute regional ischemia/reperfusion in neonatal rat ventricular myocyte monolayers.. 118. 2008
Incidence and risk factors for stroke in American Indians: the Strong Heart Study.. 118. 2008
Dynamic mechanism for initiation of ventricular fibrillation in vivo.. 118. 2008
Prevalence and prognostic significance of preprocedural cardiac troponin elevation among patients with stable coronary artery disease undergoing percutaneous coronary intervention: results from the evaluation of drug eluting stents and ischemic events registry.. 118. 2008
Phase 1b randomized study of antidote-controlled modulation of factor IXa activity in patients with stable coronary artery disease.. 117. 2008
Left ventricular morphology and systolic function in sleep-disordered breathing: the Sleep Heart Health Study.. 117. 2008
Cardiac autonomic dysfunction: effects from particulate air pollution and protection by dietary methyl nutrients and metabolic polymorphisms.. 117. 2008
Effect of rosuvastatin therapy on coronary artery stenoses assessed by quantitative coronary angiography: a study to evaluate the effect of rosuvastatin on intravascular ultrasound-derived coronary atheroma burden.. 117. 2008
Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction.. 117. 2008
Utility of cardiac monitoring in fetuses at risk for congenital heart block: the PR Interval and Dexamethasone Evaluation (PRIDE) prospective study.. 117. 2008
Noninvasive in vivo imaging of monocyte trafficking to atherosclerotic lesions.. 117. 2008
Time to coronary angiography and outcomes among patients with high-risk non ST-segment elevation acute coronary syndromes: results from the SYNERGY trial.. 116. 2007
Left ventricular untwisting rate by speckle tracking echocardiography.. 116. 2007
Differentiation, survival, and function of embryonic stem cell derived endothelial cells for ischemic heart disease.. 116. 2007
Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies.. 116. 2007
Tyrosine hydroxylase, the rate-limiting enzyme in catecholamine biosynthesis: discovery of common human genetic variants governing transcription, autonomic activity, and blood pressure in vivo.. 116. 2007
Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.. 116. 2007
Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection.. 116. 2007
Systemic lupus erythematosus predicts increased left ventricular mass.. 116. 2007
L-arginine supplementation in peripheral arterial disease: no benefit and possible harm.. 116. 2007
Prevalence and prognostic significance of wall-motion abnormalities in adults without clinically recognized cardiovascular disease: the Strong Heart Study.. 116. 2007
Cardiac improvement during mechanical circulatory support: a prospective multicenter study of the LVAD Working Group.. 115. 2007
Mechanism underlying initiation of paroxysmal atrial flutter/atrial fibrillation by ectopic foci: a simulation study.. 115. 2007
Global diastolic strain rate for the assessment of left ventricular relaxation and filling pressures.. 115. 2007
Cardiac and systemic hemodynamic characteristics of hypertension and prehypertension in adolescents and young adults: the Strong Heart Study.. 115. 2007
First-in-human experience of an antidote-controlled anticoagulant using RNA aptamer technology: a phase 1a pharmacodynamic evaluation of a drug-antidote pair for the controlled regulation of factor IXa activity.. 114. 2006
Survival after heart transplantation is not diminished among recipients with uncomplicated diabetes mellitus: an analysis of the United Network of Organ Sharing database.. 114. 2006
T-cell immunity to subclinical cytomegalovirus infection reduces cardiac allograft disease.. 114. 2006
Association between the UGT1A1*28 allele, bilirubin levels, and coronary heart disease in the Framingham Heart Study.. 114. 2006
Is it appropriate to make statins available over the counter? Over-the-counter statins are worth considering in primary prevention of cardiovascular disease.. 114. 2006
Atrioventricular ring reentry in embryonic mouse hearts.. 114. 2006
Adenoviral human BCL-2 transgene expression attenuates early donor cell death after cardiomyoblast transplantation into ischemic rat hearts.. 114. 2006
Inhibition of Toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury.. 114. 2006
Low-dose dobutamine tissue-tagged magnetic resonance imaging with 3-dimensional strain analysis allows assessment of myocardial viability in patients with ischemic cardiomyopathy.. 114. 2006
Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study.. 113. 2006
Impact of diabetes mellitus on regression of electrocardiographic left ventricular hypertrophy and the prediction of outcome during antihypertensive therapy: the Losartan Intervention For Endpoint (LIFE) Reduction in Hypertension Study.. 113. 2006
Advanced glycation end products activate a chymase-dependent angiotensin II-generating pathway in diabetic complications.. 113. 2006
Integrated electroanatomic mapping with three-dimensional computed tomographic images for real-time guided ablations.. 113. 2006
Electrocardiographic strain pattern and prediction of new-onset congestive heart failure in hypertensive patients: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) study.. 113. 2005
Decreased neurotrophin TrkB receptor expression reduces lesion size in the apolipoprotein E-null mutant mouse.. 112. 2005
TLR2 and MyD88 contribute to Lactobacillus casei extract-induced focal coronary arteritis in a mouse model of Kawasaki disease.. 112. 2005
Comparison of percutaneous coronary intervention and coronary artery bypass grafting after acute myocardial infarction complicated by cardiogenic shock: results from the Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock (SHOCK) trial.. 112. 2005
Metabolic imaging with beta-methyl-p-[(123)I]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia.. 112. 2005
Dimethylarginine dimethylaminohydrolase overexpression suppresses graft coronary artery disease.. 112. 2005
Arterial versus venous bypass grafts in patients with in-stent restenosis.. 112. 2005
Coronary artery bypass grafting in patients with low ejection fraction.. 112. 2005
Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.. 112. 2005
Implantation in coronary circulation induces morphofunctional transformation of radial grafts from muscular to elastomuscular.. 112. 2005
Novel injectable bioartificial tissue facilitates targeted, less invasive, large-scale tissue restoration on the beating heart after myocardial injury.. 112. 2005
Surgical treatment of atrial fibrillation using argon-based cryoablation during concomitant cardiac procedures.. 112. 2005
C-reactive protein as a predictor of cardiovascular risk in a population with a high prevalence of diabetes: the Strong Heart Study.. 112. 2005
Reversal of cardiomyopathy in patients with repetitive monomorphic ventricular ectopy originating from the right ventricular outflow tract.. 112. 2005
Targeted deletion of Fgl-2/fibroleukin in the donor modulates immunologic response and acute vascular rejection in cardiac xenografts.. 112. 2005
Doppler estimation of left ventricular filling pressures in patients with mitral valve disease.. 111. 2005
D-4F induces heme oxygenase-1 and extracellular superoxide dismutase, decreases endothelial cell sloughing, and improves vascular reactivity in rat model of diabetes.. 111. 2005
Stimulation of paracrine pathways with growth factors enhances embryonic stem cell engraftment and host-specific differentiation in the heart after ischemic myocardial injury.. 111. 2005
Body build and risk of cardiovascular events in hypertension and left ventricular hypertrophy: the LIFE (Losartan Intervention For Endpoint reduction in hypertension) study.. 111. 2005
Overexpression of dimethylarginine dimethylaminohydrolase reduces tissue asymmetric dimethylarginine levels and enhances angiogenesis.. 111. 2005
Ischemic stroke subtype incidence among whites, blacks, and Hispanics: the Northern Manhattan Study.. 111. 2005
Cytokine preconditioning promotes codifferentiation of human fetal liver CD133+ stem cells into angiomyogenic tissue.. 111. 2005
Vascular endothelial dysfunction and mortality risk in patients with chronic heart failure.. 111. 2005
Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104).. 110. 2004
Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia.. 110. 2004
Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: the Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial.. 110. 2004
Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium.. 110. 2004
Involvement of the serotonin 5-HT2B receptor in cardiac hypertrophy linked to sympathetic stimulation: control of interleukin-6, interleukin-1beta, and tumor necrosis factor-alpha cytokine production by ventricular fibroblasts.. 110. 2004
Is the impact of hospital and surgeon volumes on the in-hospital mortality rate for coronary artery bypass graft surgery limited to patients at high risk?. 110. 2004
Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.. 110. 2004
Neurological events during long-term mechanical circulatory support for heart failure: the Randomized Evaluation of Mechanical Assistance for the Treatment of Congestive Heart Failure (REMATCH) experience.. 109. 2004
Optimal noninvasive assessment of left ventricular filling pressures: a comparison of tissue Doppler echocardiography and B-type natriuretic peptide in patients with pulmonary artery catheters.. 109. 2004
Propensity analysis of long-term survival after surgical or percutaneous revascularization in patients with multivessel coronary artery disease and high-risk features.. 109. 2004
Non-polymer-based paclitaxel-coated coronary stents for the treatment of patients with de novo coronary lesions: angiographic follow-up of the DELIVER clinical trial.. 109. 2004
Characterization of left ventricular diastolic function by tissue Doppler imaging and clinical status in children with hypertrophic cardiomyopathy.. 109. 2004
Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).. 109. 2004
Developmental endothelial locus-1 (Del-1), a novel angiogenic protein: its role in ischemia.. 109. 2004
Pitavastatin downregulates expression of the macrophage type B scavenger receptor, CD36.. 109. 2004
Relationship of high and low ankle brachial index to all-cause and cardiovascular disease mortality: the Strong Heart Study.. 109. 2004
Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.. 109. 2004
Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis.. 109. 2004
Differential treatment benefit of platelet glycoprotein IIb/IIIa inhibition with percutaneous coronary intervention versus medical therapy for acute coronary syndromes: exploration of methods.. 109. 2004
Images in cardiovascular medicine. Avoiding papillary muscle infarction with myocardial contrast echocardiographic guidance of nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 109. 2004
Cytomegalovirus infection impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine in transplant arteriosclerosis.. 109. 2004
Dimethylarginine dimethylaminohydrolase regulates nitric oxide synthesis: genetic and physiological evidence.. 108. 2003
Anatomic stereotactic catheter ablation on three-dimensional magnetic resonance images in real time.. 108. 2003
Gadolinium cardiovascular magnetic resonance predicts reversible myocardial dysfunction and remodeling in patients with heart failure undergoing beta-blocker therapy.. 108. 2003
Effects of eplerenone, enalapril, and eplerenone/enalapril in patients with essential hypertension and left ventricular hypertrophy: the 4E-left ventricular hypertrophy study.. 108. 2003
The -174G/C interleukin-6 polymorphism influences postoperative interleukin-6 levels and postoperative atrial fibrillation. Is atrial fibrillation an inflammatory complication?. 108 Suppl 1. 2003
Transcatheter angioplasty for acquired pulmonary vein stenosis after radiofrequency ablation.. 108. 2003
Long-term results of the radial artery used for myocardial revascularization.. 108. 2003
Safety of an aspirin-alone regimen after intracoronary stenting with a heparin-coated stent: final results of the HOPE (HEPACOAT and an Antithrombotic Regimen of Aspirin Alone) study.. 108. 2003
Antioxidant vitamins C and E improve endothelial function in children with hyperlipidemia: Endothelial Assessment of Risk from Lipids in Youth (EARLY) Trial.. 108. 2003
Endothelial dysfunction induced by hyperhomocyst(e)inemia: role of asymmetric dimethylarginine.. 108. 2003
Do hospitals and surgeons with higher coronary artery bypass graft surgery volumes still have lower risk-adjusted mortality rates?. 108. 2003
Regression of electrocardiographic left ventricular hypertrophy by losartan versus atenolol: The Losartan Intervention for Endpoint reduction in Hypertension (LIFE) Study.. 108. 2003
Tissue Doppler imaging predicts the development of hypertrophic cardiomyopathy in subjects with subclinical disease.. 108. 2003
Coronary artery disease risk in familial combined hyperlipidemia and familial hypertriglyceridemia: a case-control comparison from the National Heart, Lung, and Blood Institute Family Heart Study.. 108. 2003
Spatial distribution of phase singularities in ventricular fibrillation.. 108. 2003
Overexpression of the serotonin 5-HT2B receptor in heart leads to abnormal mitochondrial function and cardiac hypertrophy.. 107. 2003
Risks of using internal thoracic artery grafts in patients in chronic hemodialysis via upper extremity arteriovenous fistula.. 107. 2003
Low-density lipoprotein in hypercholesterolemic human plasma induces vascular endothelial cell apoptosis by inhibiting fibroblast growth factor 2 transcription.. 107. 2003
Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis.. 107. 2003
Beating atrial septal defect closure monitored by epicardial real-time three-dimensional echocardiography without cardiopulmonary bypass.. 107. 2003
Identification of hibernating myocardium with quantitative intravenous myocardial contrast echocardiography: comparison with dobutamine echocardiography and thallium-201 scintigraphy.. 107. 2003
Nicotine strongly activates dendritic cell-mediated adaptive immunity: potential role for progression of atherosclerotic lesions.. 107. 2003
Echocardiographic predictors of survival and response to early revascularization in cardiogenic shock.. 107. 2003
Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia.. 106. 2002
Response to adenosine differentiates focal from macroreentrant atrial tachycardia: validation using three-dimensional electroanatomic mapping.. 106. 2002
Long-term outcome of patients treated with repeat percutaneous coronary intervention after failure of gamma-brachytherapy for the treatment of in-stent restenosis.. 106. 2002
Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase.. 106. 2002
Microvascular structural correlates of myocardial contrast echocardiography in patients with coronary artery disease and left ventricular dysfunction: implications for the assessment of myocardial hibernation.. 106. 2002
Acute effect of nonsurgical septal reduction therapy on regional left ventricular asynchrony in patients with hypertrophic obstructive cardiomyopathy.. 106. 2002
Change in systolic left ventricular performance after 3 years of antihypertensive treatment: the Losartan Intervention for Endpoint (LIFE) Study.. 106. 2002
First experience with direct factor Xa inhibition in patients with stable coronary disease: a pharmacokinetic and pharmacodynamic evaluation.. 105. 2002
Angiotensinogen genotype affects renal and adrenal responses to angiotensin II in essential hypertension.. 105. 2002
Mitral ratio of peak early to late diastolic filling velocity as a predictor of mortality in middle-aged and elderly adults: the Strong Heart Study.. 105. 2002
Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience.. 105. 2002
Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload.. 105. 2002
Plasma homocysteine concentration, statin therapy, and the risk of first acute coronary events.. 105. 2002
Markers of increased risk of intracerebral hemorrhage after intravenous recombinant tissue plasminogen activator therapy for acute ischemic stroke in clinical practice: the Multicenter rt-PA Stroke Survey.. 105. 2002
Increased myocardial gene expression of tumor necrosis factor-alpha and nitric oxide synthase-2: a potential mechanism for depressed myocardial function in hibernating myocardium in humans.. 105. 2002
The cardiology patient page. Statins: powerful drugs for lowering cholesterol: advice for patients.. 105. 2002
Change in diastolic left ventricular filling after one year of antihypertensive treatment: The Losartan Intervention For Endpoint Reduction in Hypertension (LIFE) Study.. 105. 2002
Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: double-blind, randomized, controlled clinical trial.. 105. 2002
Principal component analysis of the T wave and prediction of cardiovascular mortality in American Indians: the Strong Heart Study.. 105. 2002
Statins have biphasic effects on angiogenesis.. 105. 2002
Platelet-derived growth factor-AB limits the extent of myocardial infarction in a rat model: feasibility of restoring impaired angiogenic capacity in the aging heart.. 105. 2002
Noninvasive assessment of coronary microcirculatory function in postmenopausal women and effects of short-term and long-term estrogen administration.. 105. 2002
Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS).. 104. 2001
Adenovirus-mediated heme oxygenase-1 gene delivery inhibits injury-induced vascular neointima formation.. 104. 2001
beta-blockers before percutaneous coronary intervention do not attenuate postprocedural creatine kinase isoenzyme rise.. 104. 2001
Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine.. 104. 2001
Allopurinol improves myocardial efficiency in patients with idiopathic dilated cardiomyopathy.. 104. 2001
Novel cardiac troponin T mutation as a cause of familial dilated cardiomyopathy.. 104. 2001
AHA/ACC Scientific Statement: AHA/ACC guidelines for preventing heart attack and death in patients with atherosclerotic cardiovascular disease: 2001 update: A statement for healthcare professionals from the American Heart Association and the American College of Cardiology.. 104. 2001
Clinical and angiographic effects of chronic calcium channel blocker therapy continued beyond first postoperative year in patients with radial artery grafts: results of a prospective randomized investigation.. 104. 2001
Effects of once-daily angiotensin-converting enzyme inhibition and calcium channel blockade-based antihypertensive treatment regimens on left ventricular hypertrophy and diastolic filling in hypertension: the prospective randomized enalapril study evaluating regression of ventricular enlargement (preserve) trial.. 104. 2001
Heterogeneous expression of Gap junction channels in the heart leads to conduction defects and ventricular dysfunction.. 104. 2001
Abciximab readministration: results of the ReoPro Readministration Registry.. 104. 2001
Adenovirus-mediated gene transfer of VEGF(121) improves lower-extremity endothelial function and flow reserve.. 104. 2001
Left ventricular remodeling in transgenic mice with cardiac restricted overexpression of tumor necrosis factor.. 104. 2001
Cardiac hypertrophy after transplantation is associated with persistent expression of tumor necrosis factor-alpha.. 104. 2001
Comparison of right and left ventricular responses to left ventricular assist device support in patients with severe heart failure: a primary role of mechanical unloading underlying reverse remodeling.. 104. 2001
Development and testing of the Helex septal occluder, a new expanded polytetrafluoroethylene atrial septal defect occlusion system.. 104. 2001
Mechanoelectrical feedback: role of beta-adrenergic receptor activation in mediating load-dependent shortening of ventricular action potential and refractoriness.. 104. 2001
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.. 104. 2001
Pharmacodynamics and pharmacokinetics of higher-dose, double-bolus eptifibatide in percutaneous coronary intervention.. 104. 2001
Simvastatin induces regression of cardiac hypertrophy and fibrosis and improves cardiac function in a transgenic rabbit model of human hypertrophic cardiomyopathy.. 104. 2001
Tissue Doppler imaging consistently detects myocardial abnormalities in patients with hypertrophic cardiomyopathy and provides a novel means for an early diagnosis before and independently of hypertrophy.. 104. 2001
Identification of a chromosome 11q23.2-q24 locus for familial aortic aneurysm disease, a genetically heterogeneous disorder.. 103. 2001
Controlled trial of intravenous immune globulin in recent-onset dilated cardiomyopathy.. 103. 2001
Long-term effects of intracoronary beta-radiation in balloon- and stent-injured porcine coronary arteries.. 103. 2001
Decreased expression of tumor necrosis factor-alpha and regression of hypertrophy after nonsurgical septal reduction therapy for patients with hypertrophic obstructive cardiomyopathy.. 103. 2001
Regression of left ventricular hypertrophy after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 103. 2001
Deceleration time in ischemic cardiomyopathy: relation to echocardiographic and scintigraphic indices of myocardial viability and functional recovery after revascularization.. 103. 2001
Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.. 103. 2001
Transforming growth factor-beta(1) stimulates L-arginine transport and metabolism in vascular smooth muscle cells: role in polyamine and collagen synthesis.. 103. 2001
Hemodynamic effects of tezosentan, an intravenous dual endothelin receptor antagonist, in patients with class III to IV congestive heart failure.. 103. 2001
Relations of stroke volume and cardiac output to body composition: the strong heart study.. 103. 2001
Effect of type 2 diabetes mellitus on left ventricular geometry and systolic function in hypertensive subjects: Hypertension Genetic Epidemiology Network (HyperGEN) study.. 103. 2001
Enhanced efficacy of eptifibatide administration in patients with acute coronary syndrome requiring in-hospital coronary artery bypass grafting. PURSUIT Investigators.. 102. 2000
Chronic unloading by left ventricular assist device reverses contractile dysfunction and alters gene expression in end-stage heart failure.. 102. 2000
Altered adrenergic receptor density in myocardial hibernation in humans: A possible mechanism of depressed myocardial function.. 102. 2000
Rapid and efficient vascular transport of arginine polymers inhibits myointimal hyperplasia.. 102. 2000
Photoangioplasty for human peripheral atherosclerosis: results of a phase I trial of photodynamic therapy with motexafin lutetium (Antrin).. 102. 2000
Angiotensin II receptor subtypes in the skeletal muscle vasculature of patients with severe congestive heart failure.. 102. 2000
American College of Cardiology/American Heart Association Clinical Competence Statement on Stress Testing. A Report of the American College of Cardiology/American Heart Association/American College of Physicians-American Society of Internal Medicine Task Force on Clinical Competence.. 102. 2000
The unclampable ascending aorta in coronary artery bypass patients: A surgical challenge of increasing frequency.. 102. 2000
Angiogenesis is impaired by hypercholesterolemia: role of asymmetric dimethylarginine.. 102. 2000
Tissue Doppler imaging consistently detects myocardial contraction and relaxation abnormalities, irrespective of cardiac hypertrophy, in a transgenic rabbit model of human hypertrophic cardiomyopathy.. 102. 2000
Management of patients with acute coronary syndromes in the United States by platelet glycoprotein IIb/IIIa inhibition. Insights from the platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial.. 102. 2000
Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.. 102. 2000
High levels of platelet inhibition with abciximab despite heightened platelet activation and aggregation during thrombolysis for acute myocardial infarction: results from TIMI (thrombolysis in myocardial infarction) 14.. 101. 2000
Impact of diabetes on cardiac structure and function: the strong heart study.. 101. 2000
Transthoracic cardioversion of atrial fibrillation: comparison of rectilinear biphasic versus damped sine wave monophasic shocks.. 101. 2000
Effects of abciximab, ticlopidine, and combined Abciximab/Ticlopidine therapy on platelet and leukocyte function in patients undergoing coronary angioplasty.. 101. 2000
Myocardial infarction in treated hypertensive patients: the paradox of lower incidence but higher mortality in young blacks compared with whites.. 101. 2000
Identification of patients at increased risk of first unheralded acute myocardial infarction by electron-beam computed tomography.. 101. 2000
Early percutaneous coronary intervention, platelet inhibition with eptifibatide, and clinical outcomes in patients with acute coronary syndromes. PURSUIT Investigators.. 101. 2000
Left ventricular geometry and function preceding neurally mediated syncope.. 101. 2000
Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS).. 101. 2000
Severity of coronary artery calcification by electron beam computed tomography predicts silent myocardial ischemia.. 101. 2000
Relation of left ventricular diastolic properties to systolic function in arterial hypertension.. 101. 2000
Assessment of QT interval and QT dispersion for prediction of all-cause and cardiovascular mortality in American Indians: The Strong Heart Study.. 101. 2000
Risk factors, angiographic patterns, and outcomes in patients with ventricular septal defect complicating acute myocardial infarction. GUSTO-I (Global Utilization of Streptokinase and TPA for Occluded Coronary Arteries) Trial Investigators.. 101. 2000
Optimizing the percutaneous interventional outcomes for patients with diabetes mellitus: results of the EPISTENT (Evaluation of platelet IIb/IIIa inhibitor for stenting trial) diabetic substudy.. 100. 1999
Identification of optimal conditions for lung graft storage with Euro-Collins solution by use of a rat orthotopic lung transplant model.. 100. 1999
Local L-arginine delivery after balloon angioplasty reduces monocyte binding and induces apoptosis.. 100. 1999
Role of papillary muscle in the generation and maintenance of reentry during ventricular tachycardia and fibrillation in isolated swine right ventricle.. 100. 1999
Decreased expression of tumor necrosis factor-alpha in failing human myocardium after mechanical circulatory support : A potential mechanism for cardiac recovery.. 100. 1999
Mononuclear cell adherence to cultured endothelium is enhanced by hypertension and insulin resistance in healthy nondiabetic volunteers.. 100. 1999
Angiogenesis gene therapy: phase I assessment of direct intramyocardial administration of an adenovirus vector expressing VEGF121 cDNA to individuals with clinically significant severe coronary artery disease.. 100. 1999
Desmin mutation responsible for idiopathic dilated cardiomyopathy.. 100. 1999
Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans.. 100. 1999
Simultaneous multisite mapping of the right and the left atrial septum in the canine intact beating heart.. 100. 1999
Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase.. 99. 1999
Clinical significance of thrombocytopenia during a non-ST-elevation acute coronary syndrome. The platelet glycoprotein IIb/IIIa in unstable angina: receptor suppression using integrilin therapy (PURSUIT) trial experience.. 99. 1999
Prevalence of myocardial viability as detected by positron emission tomography in patients with ischemic cardiomyopathy.. 99. 1999
Abciximab facilitates the rate and extent of thrombolysis: results of the thrombolysis in myocardial infarction (TIMI) 14 trial. The TIMI 14 Investigators.. 99. 1999
Multicenter clinical trial to evaluate the efficacy of correction for photon attenuation and scatter in SPECT myocardial perfusion imaging.. 99. 1999
Rising tide of cardiovascular disease in American Indians. The Strong Heart Study.. 99. 1999
Sustained suppression of ischemic complications of coronary intervention by platelet GP IIb/IIIa blockade with abciximab: one-year outcome in the EPILOG trial. Evaluation in PTCA to Improve Long-term Outcome with abciximab GP IIb/IIIa blockade.. 99. 1999
Cellular effects of beta-particle delivery on vascular smooth muscle cells and endothelial cells: a dose-response study.. 99. 1999
Induction of neurally mediated syncope with adenosine.. 99. 1999
Endogenous nitric oxide synthase inhibitor: a novel marker of atherosclerosis.. 99. 1999
Regression of atherosclerosis: role of nitric oxide and apoptosis.. 99. 1999
Influence of low HDL on progression of coronary artery disease and response to fluvastatin therapy.. 99. 1999
L-Arginine normalizes coronary vasomotion in long-term smokers.. 99. 1999
Changes in left ventricular diastolic function 6 months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy.. 99. 1999
Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy.. 99. 1999
Long-term prognostic value of exercise echocardiography compared with exercise 201Tl, ECG, and clinical variables in patients evaluated for coronary artery disease.. 98. 1998
Relations of left ventricular mass to fat-free and adipose body mass: the strong heart study. The Strong Heart Study Investigators.. 98. 1998
TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.. 98. 1998
Evidence for unconscious memory processing during elective cardiac surgery.. 98. 1998
Intensive medical therapy versus coronary angioplasty for suppression of myocardial ischemia in survivors of acute myocardial infarction: a prospective, randomized pilot study.. 98. 1998
Asymmetric dimethylarginine (ADMA): a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia.. 98. 1998
Echocardiography-guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy.. 98. 1998
Doppler estimation of left ventricular filling pressure in sinus tachycardia. A new application of tissue doppler imaging.. 98. 1998
Pharmacodynamic efficacy, clinical safety, and outcomes after prolonged platelet Glycoprotein IIb/IIIa receptor blockade with oral xemilofiban: results of a multicenter, placebo-controlled, randomized trial.. 98. 1998
Randomized, placebo-controlled trial of platelet glycoprotein IIb/IIIa blockade with primary angioplasty for acute myocardial infarction. ReoPro and Primary PTCA Organization and Randomized Trial (RAPPORT) Investigators.. 98. 1998
Limb blood flow during exercise is dependent on nitric oxide.. 98. 1998
Effects of long-term smoking on myocardial blood flow, coronary vasomotion, and vasodilator capacity.. 98. 1998
Induction of cyclooxygenase-2 and activation of nuclear factor-kappaB in myocardium of patients with congestive heart failure.. 98. 1998
The cost-effectiveness of automatic implantable cardiac defibrillators: results from MADIT. Multicenter Automatic Defibrillator Implantation Trial.. 97. 1998
Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial.. 97. 1998
Diabetes mellitus, glycoprotein IIb/IIIa blockade, and heparin: evidence for a complex interaction in a multicenter trial. EPILOG Investigators.. 97. 1998
Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance.. 97. 1998
Three-dimensional electrophysiological imaging of the intact canine left ventricle using a noncontact multielectrode cavitary probe: study of sinus, paced, and spontaneous premature beats.. 97. 1998
Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases: the Atherosclerosis Risk In Communities (ARIC) study.. 96. 1997
Assessment of myocardial viability with 99mTc-sestamibi tomography before coronary bypass graft surgery: correlation with histopathology and postoperative improvement in cardiac function.. 96. 1997
Channel patency and neovascularization after transmyocardial revascularization using an excimer laser: results and comparisons to nonlased channels.. 96. 1997
Heart rate adjustment of exercise-induced ST-segment depression identifies men who benefit from a risk factor reduction program.. 96. 1997
Impact of minimum hematocrit during cardiopulmonary bypass on mortality in patients undergoing coronary artery surgery.. 96. 1997
Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study.. 96. 1997
Adenosine-sensitive ventricular tachycardia: right ventricular abnormalities delineated by magnetic resonance imaging.. 96. 1997
Sustained platelet glycoprotein IIb/IIIa blockade with oral xemilofiban in 170 patients after coronary stent deployment.. 96. 1997
Nitric oxide regulates monocyte chemotactic protein-1.. 96. 1997
Inhibition of vascular smooth muscle cell proliferation and neointimal accumulation by adenovirus-mediated gene transfer of cytosine deaminase.. 96. 1997
Intracoronary Doppler assessment of moderate coronary artery disease: comparison with 201Tl imaging and coronary angiography. FACTS Study Group.. 96. 1997
High-dose heparin decreases nitric oxide production by cultured bovine endothelial cells.. 95. 1997
Local intramural delivery of L-arginine enhances nitric oxide generation and inhibits lesion formation after balloon angioplasty.. 95. 1997
Nitroglycerin-augmented 201T1 reinjection enhances detection of reversible myocardial hypoperfusion. A randomized, double-blind, parallel, placebo-controlled trial.. 95. 1997
Stroke volume and cardiac output in normotensive children and adults. Assessment of relations with body size and impact of overweight.. 95. 1997
Vasopressin deficiency contributes to the vasodilation of septic shock.. 95. 1997
Combined accelerated tissue-plasminogen activator and platelet glycoprotein IIb/IIIa integrin receptor blockade with Integrilin in acute myocardial infarction. Results of a randomized, placebo-controlled, dose-ranging trial. IMPACT-AMI Investigators.. 95. 1997
Dobutamine echocardiography and quantitative rest-redistribution 201Tl tomography in myocardial hibernation. Relation of contractile reserve to 201Tl uptake and comparative prediction of recovery of function.. 95. 1997
Continuous subcutaneous angiopeptin treatment significantly reduces neointimal hyperplasia in a porcine coronary in-stent restenosis model.. 95. 1997
Chronotropic response to exercise. Improved performance of ST-segment depression criteria after adjustment for heart rate reserve.. 94. 1996
Mechanism of ventricular rate control after radiofrequency modification of atrioventricular conduction in patients with atrial fibrillation.. 94. 1996
Prognostic value of exercise 201Tl tomography in patients treated with thrombolytic therapy during acute myocardial infarction.. 94. 1996
Assessment of left ventricular filling pressures by Doppler in the presence of atrial fibrillation.. 94. 1996
Age and outcome with contemporary thrombolytic therapy. Results from the GUSTO-I trial. Global Utilization of Streptokinase and TPA for Occluded coronary arteries trial.. 94. 1996
Recombinant mitotoxin basic fibroblast growth factor-saporin reduces venous anastomotic intimal hyperplasia in the arteriovenous graft.. 94. 1996
Fluid flow inhibits endothelial adhesiveness. Nitric oxide and transcriptional regulation of VCAM-1.. 94. 1996
Assessment of myocardial viability with 99mTc sestamibi in patients undergoing cardiac transplantation. A scintigraphic/pathological study.. 94. 1996
Differential dose-response to oral xemilofiban after antecedent intravenous abciximab. Administration for complex coronary intervention.. 94. 1996
Arterial remodeling after coronary angioplasty: a serial intravascular ultrasound study.. 94. 1996
Impaired heart rate response to graded exercise. Prognostic implications of chronotropic incompetence in the Framingham Heart Study.. 93. 1996
Levels of soluble cell adhesion molecules in patients with dyslipidemia.. 93. 1996
Expression of inducible nitric oxide synthase in human heart failure.. 93. 1996
Relation of mean right atrial pressure to echocardiographic and Doppler parameters of right atrial and right ventricular function.. 93. 1996
Induction of nitric oxide synthase in the human cardiac allograft is associated with contractile dysfunction of the left ventricle.. 93. 1996
Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart.. 93. 1996
Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension.. 93. 1996
Exposure to shear stress alters endothelial adhesiveness. Role of nitric oxide.. 92. 1995
Localization of a gene responsible for familial dilated cardiomyopathy to chromosome 1q32.. 92. 1995
Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells.. 92. 1995
Angiotensin-I converting enzyme genotypes and left ventricular hypertrophy in patients with hypertrophic cardiomyopathy.. 92. 1995
Double-blind, placebo-controlled study of the long-term efficacy of carvedilol in patients with severe chronic heart failure.. 92. 1995
Expression and functional significance of tumor necrosis factor receptors in human myocardium.. 92. 1995
Fibrinolysis inhibits shear stress-induced platelet aggregation.. 92. 1995
Gender-specific criteria and performance of the exercise electrocardiogram.. 92. 1995
Mechanism of repetitive monomorphic ventricular tachycardia.. 92. 1995
Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction. Results of the SOLVD echocardiography substudy.. 91. 1995
Vascular smooth muscle cell heme oxygenases generate guanylyl cyclase-stimulatory carbon monoxide.. 91. 1995
Multicenter, randomized, double-blind, placebo-controlled trial of the platelet integrin glycoprotein IIb/IIIa blocker Integrelin in elective coronary intervention. IMPACT Investigators.. 91. 1995
Comparative real-time effects on platelet adhesion and aggregation under flowing conditions of in vivo aspirin, heparin, and monoclonal antibody fragment against glycoprotein IIb-IIIa.. 91. 1995
Shear-induced platelet aggregation is inhibited by in vivo infusion of an anti-glycoprotein IIb/IIIa antibody fragment, c7E3 Fab, in patients undergoing coronary angioplasty.. 91. 1995
Dobutamine echocardiography in myocardial hibernation. Optimal dose and accuracy in predicting recovery of ventricular function after coronary angioplasty.. 91. 1995
Fractal clustering of ventricular ectopy correlates with sympathetic tone preceding ectopic beats.. 91. 1995
Metabolic determinants of defibrillation. Role of adenosine.. 91. 1995
Comparison of clinical and angiographic outcomes after saphenous vein graft angioplasty using coronary versus 'biliary' tubular slotted stents.. 91. 1995
Mortality within 24 hours of thrombolysis for myocardial infarction. The importance of early reperfusion. The GUSTO Investigators, Global Utilization of Streptokinase and Tissue Plasminogen Activator for Occluded Coronary Arteries.. 90. 1994
Role of arterial chemoreceptors in mediating the effects of endogenous adenosine on sympathetic nerve activity.. 90. 1994
Inhibition of platelet deposition and lysis of intracoronary thrombus during balloon angioplasty using urokinase-coated hydrogel balloons.. 90. 1994
Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty.. 90. 1994
Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only.. 90. 1994
Impact of age on clinical outcome and postlytic management strategies in patients treated with intravenous thrombolytic therapy. Results from the TIMI II Study. TIMI II Investigators.. 90. 1994
Mechanism-specific effects of adenosine on atrial tachycardia.. 89. 1994
Enhanced endothelial adhesiveness in hypercholesterolemia is attenuated by L-arginine.. 89. 1994
Effect of L-arginine on coronary endothelial function in cardiac transplant recipients. Relation to vessel wall morphology.. 89. 1994
Recombinant hirudin for unstable angina pectoris. A multicenter, randomized angiographic trial.. 89. 1994
Vascular injury augments adrenergic neurotransmission.. 89. 1994
Combination antithrombotic therapy in unstable rest angina and non-Q-wave infarction in nonprior aspirin users. Primary end points analysis from the ATACS trial. Antithrombotic Therapy in Acute Coronary Syndromes Research Group.. 89. 1994
Efficient and selective adenovirus-mediated gene transfer into vascular neointima.. 88. 1993
Selective pulmonary vasodilation by inhaled nitric oxide is due to hemoglobin inactivation.. 88. 1993
Value of the P-wave signal-averaged ECG for predicting atrial fibrillation after cardiac surgery.. 88. 1993
Reoperative coronary artery bypass surgery. Improved preservation of myocardial function with retrograde cardioplegia.. 88. 1993
The effects of warm versus cold blood cardioplegia on endothelial function, myocardial function, and energetics.. 88. 1993
Can further benefit be achieved by adding flosequinan to patients with congestive heart failure who remain symptomatic on diuretic, digoxin, and an angiotensin converting enzyme inhibitor? Results of the flosequinan-ACE inhibitor trial (FACET).. 88. 1993
Prognostic value and physiological correlates of heart rate variability in chronic severe mitral regurgitation.. 88. 1993
Shear stress elevates endothelial cGMP. Role of a potassium channel and G protein coupling.. 88. 1993
Angiographic and hemodynamic determinants of myocardial ischemia during adenosine thallium-201 scintigraphy in coronary artery disease.. 87. 1993
Dyslipidemia and atherosclerosis. A forecast of pharmaceutical approaches.. 87. 1993
Quantitative adenosine 201Tl single-photon emission computed tomography for the early assessment of patients surviving acute myocardial infarction.. 87. 1993
Response of nonreentrant catecholamine-mediated ventricular tachycardia to endogenous adenosine and acetylcholine. Evidence for myocardial receptor-mediated effects.. 87. 1993
Parallel cardiac and vascular adaptation in hypertension.. 86. 1992
Compositional analysis of a modified University of Wisconsin solution for extended myocardial preservation. A study of the left ventricular pressure-volume relation.. 86. 1992
Survival analysis of octogenarian patients with coronary artery disease managed by elective coronary artery bypass surgery versus conventional medical treatment.. 86. 1992
Exercise echocardiography versus 201Tl single-photon emission computed tomography in evaluation of coronary artery disease. Analysis of 292 patients.. 85. 1992
Doppler echocardiographic evaluation of pseudoaneurysms complicating composite grafts of the ascending aorta.. 85. 1992
Natural history of left ventricular performance at rest and during exercise after aortic valve replacement for aortic regurgitation.. 84. 1991
Efficacy of permanent pacing in the management of high-risk patients with long QT syndrome.. 84. 1991
Hypercholesterolemia enhances macrophage recruitment and dysfunction of regenerated endothelium after balloon injury of the rabbit iliac artery.. 84. 1991
Effect of ST segment measurement point on performance of standard and heart rate-adjusted ST segment criteria for the identification of coronary artery disease.. 84. 1991
Arginine restores cholinergic relaxation of hypercholesterolemic rabbit thoracic aorta.. 83. 1991
Heart rate adjustment of exercise-induced ST segment depression. Improved risk stratification in the Framingham Offspring Study.. 83. 1991
Doppler echocardiographic assessment of the St. Jude Medical prosthetic valve in the aortic position using the continuity equation.. 83. 1991
Sex differences in control of cutaneous blood flow.. 82. 1990
Treatment with desmopressin acetate in routine coronary artery bypass surgery to improve postoperative hemostasis.. 82. 1990
Altered myocardial perfusion in patients with angina pectoris or silent ischemia during exercise as assessed by quantitative thallium-201 single-photon emission computed tomography.. 82. 1990
Doppler assessment of right ventricular filling in a normal population. Comparison with left ventricular filling dynamics.. 82. 1990
Intravenous recombinant tissue-type plasminogen activator in patients with unstable angina pectoris. Results of a placebo-controlled, randomized trial.. 82. 1990
Diagnosis of coronary artery disease by controlled coronary vasodilation with adenosine and thallium-201 scintigraphy in patients unable to exercise.. 82. 1990
Persistent dysfunction of regenerated endothelium after balloon angioplasty of rabbit iliac artery.. 81. 1990
Effect of epicardial patch electrodes on transthoracic defibrillation.. 81. 1990
Electrophysiological effects of adenosine in the transplanted human heart. Evidence of supersensitivity.. 81. 1990
Lack of diurnal variation in the onset of non-Q wave infarction.. 81. 1990
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults.. 81. 1990
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension.. 81. 1990
Electrophysiologic effects of dipyridamole on atrioventricular nodal conduction and supraventricular tachycardia. Role of endogenous adenosine.. 80. 1989
Feasibility of tomographic 99mTc-hexakis-2-methoxy-2-methylpropyl-isonitrile imaging for the assessment of myocardial area at risk and the effect of treatment in acute myocardial infarction.. 80. 1989
Mitral valve dimensions and motion in Marfan patients with and without mitral valve prolapse. Comparison to primary mitral valve prolapse and normal subjects.. 80. 1989
Recovery-phase patterns of ST segment depression in the heart rate domain. Identification of coronary artery disease by the rate-recovery loop.. 80. 1989
Heart rate adjustment of ST segment depression for improved detection of coronary artery disease.. 79. 1989
Platelet thrombus formation on collagen type I. A model of deep vessel injury. Influence of blood rheology, von Willebrand factor, and blood coagulation.. 78. 1988
Reduced lymphocyte stimulatory guanine nucleotide regulatory protein and beta-adrenergic receptors in congestive heart failure and reversal with angiotensin converting enzyme inhibitor therapy.. 78. 1988
Quantification of infarct size by 201Tl single-photon emission computed tomography during acute myocardial infarction in humans. Comparison with enzymatic estimates.. 78. 1988
Increased preferential absorption in human atherosclerotic plaque with oral beta carotene. Implications for laser endarterectomy.. 78. 1988
Mitral valve prolapse and severe mitral regurgitation.. 78. 1988
Morning increase in platelet aggregability. Association with assumption of the upright posture.. 78. 1988
Wideband external pulse recording during cuff deflation: a new technique for evaluation of the arterial pressure pulse and measurement of blood pressure.. 77. 1988
The relationship between left ventricular systolic function and congestive heart failure diagnosed by clinical criteria.. 77. 1988
Surgical ablation of ventricular tachycardia with sequential map-guided subendocardial resection: electrophysiologic assessment and long-term follow-up.. 77. 1988
Myocardial perfusion abnormalities in patients with hypertrophic cardiomyopathy: assessment with thallium-201 emission computed tomography.. 76. 1987
Predictors of efficacy of amiodarone and characteristics of recurrence of arrhythmia in patients with sustained ventricular tachycardia and coronary artery disease.. 76. 1987
The hemodynamic effects of sotalol and quinidine: analysis by use of rest and exercise gated radionuclide angiography.. 76. 1987
Differential electrophysiologic properties of decremental retrograde pathways in long RP' tachycardia.. 76. 1987
Improved sex-specific criteria of left ventricular hypertrophy for clinical and computer interpretation of electrocardiograms: validation with autopsy findings.. 75. 1987
Association of levels of lipoprotein Lp(a), plasma lipids, and other lipoproteins with coronary artery disease documented by angiography.. 74. 1986
Adenosine-sensitive ventricular tachycardia: evidence suggesting cyclic AMP-mediated triggered activity.. 74. 1986
Surgical ablation of ventricular tachycardia: improved results with a map-directed regional approach.. 73. 1986
Mitral regurgitation: relationship of noninvasive descriptors of right and left ventricular performance to clinical and hemodynamic findings and to prognosis in medically and surgically treated patients.. 73. 1986
Efficacy and safety of moricizine in patients with ventricular tachycardia: results of a placebo-controlled prospective long-term clinical trial.. 73. 1986
Indium-111 platelet scintigraphy for the diagnosis of acute venous thrombosis.. 73. 1986
Accurate noninvasive quantification of stenotic aortic valve area by Doppler echocardiography.. 73. 1986
Maintenance of exercise stroke volume during ventricular versus atrial synchronous pacing: role of contractility.. 72. 1985
Exercise thallium-201 scintigraphy in dogs: effects of long-term coronary occlusion and collateral development on early and late scintigraphic images.. 72. 1985
Some reflections on arteriosclerosis: past, present, and future.. 72. 1985
Autoimmune myocarditis induced by Trypanosoma cruzi.. 71. 1985
Determination of parameters of left ventricular diastolic filling with pulsed Doppler echocardiography: comparison with cineangiography.. 71. 1985
Effects of age, sex, and body habitus on QRS and ST-T potential maps of 1100 normal subjects.. 71. 1985
Heritability of cardiac size: an echocardiographic and electrocardiographic study of monozygotic and dizygotic twins.. 71. 1985
Directions of atherosclerosis research in the 1980s and 1990s.. 70. 1984
Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window.. 70. 1984
Myocardial injury and induction of arrhythmia by direct current shock delivered via endocardial catheters in dogs.. 69. 1984
Recommendations for treatment of hyperlipidemia in adults. A joint statement of the Nutrition Committee and the Council on Arteriocslerosis.. 69. 1984
Comparative effect of disopyramide and ethmozine in suppressing complex ventricular arrhythmias by use of a double-blind, placebo-controlled, longitudinal crossover design.. 69. 1984
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress.. 68. 1983
Detection of coronary artery disease with exercise two-dimensional echocardiography. Description of a clinically applicable method and comparison with radionuclide ventriculography.. 67. 1983
Geometric determinants of electrocardiographic left ventricular hypertrophy.. 67. 1983
Quantification of left ventricular volumes by two-dimensional echocardiography: a simplified and accurate approach.. 67. 1983
The potential impact of nuclear magnetic resonance imaging on cardiovascular diagnosis.. 67. 1983
Occupational screenings: recruitment from private industry.. 66. 1982
The influence of residual disease after coronary bypass on the 5-year survival rate of 1274 men with coronary artery disease.. 66. 1982
Clinical results of coronary bypass in 500 patients at least 10 years after operation.. 66. 1982
Left ventricular volume and function during relief of cardiac tamponade in man.. 66. 1982
Survival after coronary artery bypass surgery in specific patient groups.. 65. 1982
Gamma camera quantitation of thallium-210 redistribution at rest in a dog model.. 65. 1982
A new, simplified and accurate method for determining ejection fraction with two-dimensional echocardiography.. 64. 1981
Left ventricular diastolic performance at rest and during exercise in patients with coronary artery disease. Assessment with first-pass radionuclide angiography.. 63. 1981
Left ventricular hypertrophy: relationship of anatomic, echocardiographic and electrocardiographic findings.. 63. 1981
A new approach for evaluating risk factors in coronary artery disease: a study of lipid concentrations and severity of disease in 1847 males.. 62. 1980
Pulsed doppler echocardiographic measurement of beat-to-beat changes in stroke volume in dogs.. 62. 1980
Bypass graft surgery in severe left ventricular dysfunction.. 62. 1980
Exercise tolerance in late survivors of balloon pumping and surgery for cardiogenic shock.. 62. 1980
Echo-phonocardiographic determination of left atrial and left ventricular filling pressures with and without mitral stenosis.. 61. 1980
Relationship between plasma lipid concentrations and coronary artery disease in 496 patients.. 56. 1977
Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method.. 55. 1977
Operative management of tricuspid regurgitation.. 54. 1976
Left atrial enlargement. Echocardiographic assessment of electrocardiographic criteria.. 54. 1976
Influence of acute changes in preload, afterload, contractile state and heart rate on ejection and isovolumic indices of myocardial contractility in man.. 53. 1976
Cerebrospinal fluid acidosis complicating therapy of experimental cardiopulmonary arrest.. 52. 1975
Long-term survival following coronary bypass surgery in patients with significant impairment of left ventricular function.. 52. 1975
Echocardiographic determination of left ventricular stress-velocity relations.. 51. 1975
Dynamic determinants of letf ventricular diastolic pressure-volume relations in man.. 51. 1975
The anatomic substrate of complete left bundle branch block.. 50. 1974
Changes in the underlying coronary circulation secondary to bypass grafting.. 50. 1974
Factors influencing long-term survival after isolated aortic valve replacement.. 50. 1974
Echocardiographic assessment of left ventricular function with special reference to normalized velocities.. 50. 1974
Reduction in the rate of diastolic descent of the mitral valve echogram in patients with altered left ventricular diastolic pressure-volume relations.. 49. 1974
Left main coronary artery stenosis; results of coronary bypass surgery.. 49. 1974
Evaluation of anticoagulant therapy in cloth-covered prosthetic valves.. 48. 1973
Effects of surgery on angina (pre- and postinfarction) and myocardical function (failure).. 46. 1972
Determinants of angiographic patency of aortocoronary vein bypass grafts.. 45. 1972
Heart failure complicating acute myocardial infarction.. 45. 1972
Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease.. 91. 1995
Response to letters regarding article, "unexpected effect of proton pump inhibitors: elevation of the cardiovascular risk factor asymmetric dimethylarginine". 2014
Is it appropriate to make statins available over the counter? The argument against the appropriateness of over-the-counter statins. 2006
A novel mechanism for pulmonary arterial hypertension? 2003
Is the electrocardiogram still useful for detection of left ventricular hypertrophy? 1990
Prevalence of Diabetes and Cardiovascular Risk in the Middle East and Africa: Primary Results of the PACT-MEA Study. 2023
Nano-miR-133a Replacement Therapy Blunts Pressure Overload-Induced Heart Failure. 2021
Response by Leor et al to Letter Regarding Article, "Extracellular Vesicles From Epicardial Fat Facilitate Atrial Fibrillation". 2021
Association Between Cervical Artery Dissection and Aortic Dissection. 2021
Molecular Imaging of Infective Endocarditis With 6''-[¹⁸F]Fluoromaltotriose Positron Emission Tomography-Computed Tomography. 2020
Response of Cardiac Surgery Units to COVID-19: An Internationally-Based Quantitative Survey. 2020
Characterization of Endovascular Abdominal Aortic Aneurysm Repair Surveillance in the Vascular Quality Initiative. 2020
Prognostic Implications of Diffuse Interstitial Fibrosis in Asymptomatic Primary Mitral Regurgitation. 2019
Hospital Volume Association With Abdominal Aortic Aneurysm Repair Mortality: Analysis of the International Consortium of Vascular Registries. 2019
Outcomes of Patients With Mediastinal Radiation-Associated Severe Aortic Stenosis Undergoing Transcatheter Aortic Valve Replacement. 2018
Sex Differences in the Etiology of Surgical Mitral Valve Disease. 2018
Response by Kamel to Letter Regarding Article, "Pregnancy and the Risk of Aortic Dissection or Rupture: A Cohort-Crossover Analysis". 2017
Coronary Endothelial Dysfunction and the Index of Microcirculatory Resistance as a Marker of Subsequent Development of Cardiac Allograft Vasculopathy. 2017
Response to Letter Regarding Article, "Southern Dietary Pattern is Associated With Hazard of Acute Coronary Heart Disease in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) Study". 2016
Response to Letter Regarding Article, "Circulating MicroRNA-30d Is Associated With Response to Cardiac Resynchronization Therapy in Heart Failure and Regulates Cardiomyocyte Apoptosis: A Translational Pilot Study". 2016
Response to Letter Regarding Article "Transdifferentiation of Human Fibroblasts to Endothelial Cells: Role of Innate Immunity". 2015
Letter from Cohen and Alderman regarding article, "lower levels of sodium intake and reduced cardiovascular risk". 2014
Response to letter regarding article, "growth properties of cardiac stem cells are a novel biomarker of patients' outcome after coronary bypass surgery". 2014
Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA/ACC risk equation. 2013
Letter by Benedetto et al regarding article, "Importance of refractory pain and hypertension in acute type B aortic dissection: insights from the International Registry of Acute Aortic Dissection (IRAD)". 2011
Letter by Wells and Eisenberg regarding article, "Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials". 2010
Letter by O'Rourke et al regarding article, "Arterial stiffness and cardiovascular events: the Framingham Heart Study". 2010
Letter by Nagueh et al regarding article, "Tissue Doppler imaging in the estimation of intracardiac filling pressure in decompensated patients with advanced systolic heart failure". 2009
Letter by Stuehlinger et al regarding article, "Metabolic profiling of arginine and nitric oxide pathways predicts hemodynamic abnormalities and mortality in patients with cardiogenic shock after acute myocardial infarction". 2008
Letter by Kielstein et al regarding article, "Renal function as a predictor of outcome in a broad spectrum of patients with heart failure". 2006
Is asymmetric dimethylarginine a novel marker of atherosclerosis? 2000
Exercise-induced ischemia and carotid atherosclerosis. 1999
Transcatheter alcohol septal ablation for hypertrophic obstructive cardiomyopathy. 1999
Rapport? 1999
Does the early hazard phenomenon exist? Do the GUSTO findings prove or disprove? 1997
Echocardiographic estimation of mean right atrial pressure: how to obtain an estimate in all patients? 1997
Dobutamine echocardiography. 1995
Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set". 1994
The academic life of a noninvasive test. 1990
Left ventricular mass in hypertension. 1990
Determinants of ECG LVH. 1980
Part 13: Neonatal Resuscitation: 2015 American Heart Association Guidelines Update for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. 2015
Part 1: Executive Summary: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2015
Part 7: Neonatal Resuscitation: 2015 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2015
AHA/ACC/HHS strategies to enhance application of clinical practice guidelines in patients with cardiovascular disease and comorbid conditions: from the American Heart Association, American College of Cardiology, and US Department of Health and Human Services. 2014
HRS/ACC/AHA expert consensus statement on the use of implantable cardioverter-defibrillator therapy in patients who are not included or not well represented in clinical trials. 2014
ACC/AHA/SCAI 2014 health policy statement on structured reporting for the cardiac catheterization laboratory: a report of the American College of Cardiology Clinical Quality Committee. 2014
SCAI/ACC/AHA expert consensus document: 2014 update on percutaneous coronary intervention without on-site surgical backup. 2014
ACCF/AHA clinical practice guideline methodology summit report: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. 2012
Part 11: Neonatal resuscitation: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2010
Part 1: Executive summary: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2010
Part 3: Evidence evaluation process: 2010 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2010
Part 4: Conflict of interest management before, during, and after the 2010 International Consensus Conference on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations. 2010
ACCF/AHA Clopidogrel clinical alert: approaches to the FDA "boxed warning": a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the American Heart Association. 2010
ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. 2008
Report of the National Heart, Lung, and Blood Institute and National Marfan Foundation Working Group on research in Marfan syndrome and related disorders. 2008
Prevention strategies for cardiovascular disease in HIV-infected patients. 2008
ACCF/ASE/ACEP/AHA/ASNC/SCAI/SCCT/SCMR 2008 appropriateness criteria for stress echocardiography: a report of the American College of Cardiology Foundation Appropriateness Criteria Task Force, American Society of Echocardiography, American College of Emergency Physicians, American Heart Association, American Society of Nuclear Cardiology, Society for Cardiovascular Angiography and Interventions, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance: endorsed by the Heart Rhythm Society and the Society of Critical Care Medicine. 2008
Scientific knowledge gaps and clinical research priorities for cardiopulmonary resuscitation and emergency cardiovascular care identified during the 2005 International Consensus Conference on ECC [corrected] and CPR science with treatment recommendations: a consensus statement from the International Liaison Committee on Resuscitation (American Heart Association, Australian Resuscitation Council, European Resuscitation Council, Heart and Stroke Foundation of Canada, InterAmerican Heart Foundation, Resuscitation Council of Southern Africa, and the New Zealand Resuscitation Council); the American Heart Association Emergency Cardiovascular Care Committee; the Stroke Council; and the Cardiovascular Nursing Council.". 2007
Universal definition of myocardial infarction. 2007
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part I. 2005
Discovering the full spectrum of cardiovascular disease: Minority Health Summit 2003: report of the Obesity, Metabolic Syndrome, and Hypertension Writing Group. 2005
Prevention Conference VII: Obesity, a worldwide epidemic related to heart disease and stroke: Group IV: prevention/treatment. 2004
ACCF/AHA consensus conference report on professionalism and ethics. 2004
Low high-density lipoprotein cholesterol as a risk factor in coronary heart disease: a working group report. 2001
American College of Cardiology/American Heart Association Expert Consensus document on electron-beam computed tomography for the diagnosis and prognosis of coronary artery disease. 2000
Lowering LDL cholesterol: questions from recent meta-analyses and subset analyses of clinical trial DataIssues from the Interdisciplinary Council on Reducing the Risk for Coronary Heart Disease, ninth Council meeting. 1999
Lipid lowering, regression, and coronary events. A review of the Interdisciplinary Council on Lipids and Cardiovascular Risk Intervention, Seventh Council meeting. 1995
Experience Is Crucial in Off-Pump Coronary Artery Bypass Grafting.. 139. 2019
Rollercoaster Blood Pressure: An Alzheimer Disease Risk Factor?. 136. 2017
Thirty-Day Readmissions for Critical Limb Ischemia: Ready for a New Quality Metric?. 136. 2017
Hypertension Treatment and Outcomes in the Era of Population Health, Coordinated Care, and Medicare Access and CHIP Reauthorization Act (MACRA).. 135. 2017
Intracerebral Hemorrhage, Racial Disparities, and Access to Care.. 134. 2016
Postpartum Hypertension: "It Ain't Over 'til It's Over".. 132. 2015
Cardiac magnetic resonance imaging and sudden death risk in patients with hypertrophic cardiomyopathy.. 130. 2014
Fibrinogen: a circulating factor in search of its genetic architecture.. 128. 2013
Newer concepts regarding adults with coronary artery aneurysms: are they all Kawasaki? Does it make a difference?. 125. 2012
Grabbing the horns of a dilemma: the duration of dual antiplatelet therapy after stent implantation.. 125. 2012
Lymphangiogenesis: a potential new therapy for lymphedema?. 125. 2012
Low-gradient "severe" aortic stenosis with normal systolic function: time to refine the guidelines?. 123. 2011
MicroRNA and mechanisms of impaired angiogenesis in diabetes mellitus.. 123. 2011
Improving lipid goal attainment: is it enough?. 120. 2009
Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist.. 117. 2008
Tyrosine hydroxylase: another piece of the genetics of hypertension puzzle.. 116. 2007
Podagra, uric acid, and cardiovascular disease.. 116. 2007
Statin therapy and the elderly: SAGE advice?. 115. 2007
Electrocardiography in women: taking the initiative.. 113. 2006
Genetic and acquired determinants of individual variability of response to antiplatelet drugs.. 108. 2003
Does leptin cause vascular disease?. 106. 2002
Reducing the risk for stroke in patients with myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudy.. 106. 2002
Nitric oxide and angiogenesis.. 105. 2002
Eligibility for lipid-lowering drug therapy in primary prevention: how do the Adult Treatment Panel II and Adult Treatment Panel III Guidelines compare?. 105. 2002
Go with the flow.. 103. 2001
Angiogenesis and atherosclerosis. The mandate broadens.. 100. 1999
Dobutamine MRI: A serious contender in pharmacological stress imaging?. 99. 1999
Triglyceride: the forgotten risk factor.. 97. 1998
Lipoprotein(a): molecular mischief in the microvasculature.. 96. 1997
Derangements of the nitric oxide synthase pathway, L-arginine, and cardiovascular diseases.. 96. 1997
Do antihypertensive drugs differ in their ability to regress left ventricular hypertrophy?. 95. 1997
Risk stratification after myocardial infarction. Clinical science versus practice behavior.. 95. 1997
Arginine: a new therapy for atherosclerosis?. 95. 1997
Intracoronary stents. A breakthrough technology or just another small step?. 89. 1994
Cytoprotective effects of nitric oxide.. 88. 1993
Serum cholesterol. Doing the right thing.. 88. 1993
'Silent ischemia,' ventricular arrhythmias, and complications of hypertension.. 85. 1992
Diet and coronary heart disease: the statistical analysis of risk.. 63. 1981
Considerations on the Management of Acute Postoperative Ischemia After Cardiac Surgery: A Scientific Statement From the American Heart Association. 2023
Sarcopenia and Cardiovascular Diseases. 2023
Evaluation and Management of Pulmonary Hypertension in Noncardiac Surgery: A Scientific Statement From the American Heart Association. 2023
2022 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. 2022
Results of the North American Complex Abdominal Aortic Debranching (NACAAD) Registry. 2022
2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. 2021
Methodological Standards for the Design, Implementation, and Analysis of Randomized Trials in Cardiac Surgery: A Scientific Statement From the American Heart Association. 2021
2021 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Neonatal Life Support; Education, Implementation, and Teams; First Aid Task Forces; and the COVID-19 Working Group. 2021
Invasive Management of Acute Myocardial Infarction Complicated by Cardiogenic Shock: A Scientific Statement From the American Heart Association. 2021
Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. 2021
Stroke Prevention in Atrial Fibrillation: Looking Forward. 2020
Fractional Flow Reserve for Coronary Artery Bypass Surgery. 2020
Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations: A Scientific Statement From the American Heart Association. 2020
Searching for Atrial Fibrillation Poststroke: A White Paper of the AF-SCREEN International Collaboration. 2019
2019 International Consensus on Cardiopulmonary Resuscitation and Emergency Cardiovascular Care Science With Treatment Recommendations: Summary From the Basic Life Support; Advanced Life Support; Pediatric Life Support; Neonatal Life Support; Education, Implementation, and Teams; and First Aid Task Forces. 2019
Arterial Grafts for Coronary Bypass: A Critical Review After the Publication of ART and RADIAL. 2019
Myocardial Revascularization Trials. 2018
Impact of Physiologic Pacing Versus Right Ventricular Pacing Among Patients With Left Ventricular Ejection Fraction Greater Than 35%: A Systematic Review for the 2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 2018
New Strategies for Surgical Myocardial Revascularization. 2018
Continuing Conundrum of Multiple Arterial Conduits for Coronary Artery Bypass Grafting. 2018
Exercise Therapy and Cardiovascular Toxicity in Cancer. 2018
Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves. 2018
Handheld Echocardiography: Current State and Future Perspectives. 2017
Mechanisms, Consequences, and Prevention of Coronary Graft Failure. 2017
Screening for Atrial Fibrillation: A Report of the AF-SCREEN International Collaboration. 2017
Pacing as a Treatment for Reflex-Mediated (Vasovagal, Situational, or Carotid Sinus Hypersensitivity) Syncope: A Systematic Review for the 2017 ACC/AHA/HRS Guideline for the Evaluation and Management of Patients With Syncope: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. 2017
Three Arterial Grafts Improve Late Survival: A Meta-Analysis of Propensity-Matched Studies. 2017
The Evolution of Coronary Bypass Surgery Will Determine Its Relevance as the Standard of Care for the Treatment for Multivessel Coronary Artery Disease. 2016
Degenerative Mitral Stenosis: Unmet Need for Percutaneous Interventions. 2016
Cardiovascular Effects of Androgen Deprivation Therapy for the Treatment of Prostate Cancer: ABCDE Steps to Reduce Cardiovascular Disease in Patients With Prostate Cancer. 2016
Are at least 12 months of dual antiplatelet therapy needed for all patients with drug-eluting stents? All patients with drug-eluting stents need at least 12 months of dual antiplatelet therapy. 2015
Anderson-Fabry disease and other lysosomal storage disorders. 2014
Left atrial appendage closure to prevent stroke in patients with atrial fibrillation. 2014
Tumors metastatic to the heart. 2013
Moving from political declaration to action on reducing the global burden of cardiovascular diseases: a statement from the global cardiovascular disease taskforce. 2013
Levels and changes of HDL cholesterol and apolipoprotein A-I in relation to risk of cardiovascular events among statin-treated patients: a meta-analysis. 2013
Cancer therapy-induced cardiac toxicity in early breast cancer: addressing the unresolved issues. 2012
Our time: a call to save preventable death from cardiovascular disease (heart disease and stroke). 2012
Genetics of peripheral artery disease. 2012
Imaging for ventricular function and myocardial recovery on nonpulsatile ventricular assist devices. 2012
Modulation of anthracycline-induced cardiotoxicity by aerobic exercise in breast cancer: current evidence and underlying mechanisms. 2011
Impact of genetic insights into mendelian disease on cardiovascular clinical practice. 2011
Part 15: neonatal resuscitation: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. 2010
Part 1: executive summary: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. 2010
Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. 2010
Current perspectives on cardiac function in patients with diastolic heart failure. 2009
Pulmonary diseases and the heart. 2007
Cardiovascular manifestations of rheumatologic diseases. 2007
Added benefit of mineralocorticoid receptor blockade in the primary prevention of sudden cardiac death. 2007
Congenital and acquired pulmonary vein stenosis. 2007
Exercise electrocardiogram testing: beyond the ST segment. 2006
Molecular basis of arrhythmias. 2005
Percutaneous recanalization of chronically occluded coronary arteries: a consensus document: part II. 2005
Exercise testing in asymptomatic adults: a statement for professionals from the American Heart Association Council on Clinical Cardiology, Subcommittee on Exercise, Cardiac Rehabilitation, and Prevention. 2005
Update on statins: 2003. 2004
Relationship between activated clotting time and ischemic or hemorrhagic complications: analysis of 4 recent randomized clinical trials of percutaneous coronary intervention. 2004
HDL cholesterol and protective factors in atherosclerosis. 2004
Inflammation in atherosclerosis and implications for therapy. 2004
Asymmetrical dimethylarginine: the Uber marker? 2004
Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in diabetic patients with non-ST-segment-elevation acute coronary syndromes. 2001
Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials. 2001
Risk reduction. 2000
Platelet glycoprotein IIb/IIIa antagonists. What are the relevant issues concerning their pharmacology and clinical use? 1999
Use of sildenafil (Viagra) in patients with cardiovascular disease. Technology and Practice Executive Committee. 1999
Cholesterol management in theory and practice. 1997
Clinical trials for claudication. Assessment of exercise performance, functional status, and clinical end points. Vascular Clinical Trialists. 1995
Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a 'new diagnostic mind-set'. 1994
Role of preclinical cardiovascular disease in the evolution from risk factor exposure to development of morbid events. 1993
Vascular biology and medicine in the 1990s: scope, concepts, potentials, and perspectives. 1993
A cascade model for restenosis. A special case of atherosclerosis progression. 1992
Cardiac electrophysiology of adenosine. Basic and clinical concepts. 1991
New perspectives for perfusion imaging in echocardiography. 1991
Mechanisms of abnormal transmembrane signaling of the beta-adrenergic receptor in congestive heart failure. 1990
The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. A joint statement by the American Heart Association and the National Heart, Lung, and Blood Institute. The Task Force on Cholesterol Issues, American Heart Association. 1990
Silent myocardial ischemia in patients with coronary artery disease. Possible links with diastolic left ventricular dysfunction. 1990
Mitral valve prolapse. 1976

VIVO Weill Cornell Medical College

Circulation Journal

Overview

publication venue for

Identity

ISO Abbreviation

Linking ISSN

International Standard Serial Number (ISSN)

Electronic International Standard Serial Number (EISSN)